Nathaniel L Elsen

13PUBLICATIONS
55CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesCheminformatics and quantitative structure-activity relationshipsProteins and peptidesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 09, 2026
Microsatellite instable cancer cells acquire on-target resistance mutations to WRN helicase inhibitors.

Faith Fowler, Jessica Gajda, Amirhossein Mafi

|Jan 30, 2026
Affinity selection mass spectrometry (AS-MS) as a tool to accelerate drug discovery efforts.

Sangeeta Pandey, Florent Samain, Omprakash Nacham

|Jun 05, 2025
Validation, Key Pharmacophores, and X-ray Cocrystal Structures of Novel Biochemically and Cellularly Active WRN Inhibitors Derived from a DNA-Encoded Library Screen.

Yunsong Tong, Kenton A Baker, Alex M Chapman

|Jul 11, 2024
Detection of Noncovalent Protein-Ligand Complexes by IR-MALDESI-MS.

Kevan T Knizner, Fan Pu, James W Sawicki

|Mar 20, 2024
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma.

Joshua P Plotnik, Adam E Richardson, Haopeng Yang

|Apr 12, 2023
New Platform for Label-Free, Proximal Cellular Pharmacodynamic Assays: Identification of Glutaminase Inhibitors Using Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry.

Fan Pu, Andrew J Radosevich, Brett G Bruckner

Pageof 3

Frequent Collaborators

9 joint publications

Jon D Williams

6 joint publications

Andrew J Radosevich

4 joint publications

David C Muddiman

2 joint publications

Sanjay C Panchal